Investors have sued Royal Caribbean Cruises in the Miami federal court over allegations that it failed to disclose pandemic-induced decreased bookings early in the year and exaggerated its ability to prevent the spread of coronavirus aboard its ships.
Labaton Sucharow LLP, on behalf of The City of Riviera Beach General Employees Retirement System, filed a securities class action lawsuit on Wednesday.
The system is seeking to represent a class of shareholders who bought stocks between early February and mid-March.
The action alleges that, from February 4, 2020, through March 17, 2020, the cruise line failed to disclose its decreased bookings outside China, saying that it was only experiencing a bookings slowdown from China.
On March 18, 2020, analysts downgraded Royal Caribbean’s stock and slashed their price targets. On this news, Royal Caribbean shares fell more than 19 percent.
Royal Caribbean had not yet been served with the complaint, according to spokesman Jonathon Fishman.
Royal Caribbean is the world’s second-largest cruise company, operating 61 cruise ships, which visit over 1,000 destinations across all seven continents.


Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
REPAY Stock Rises After Visa Platform Connect Collaboration
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Google to Move All Pixel Production Out of China by 2027
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
OpenAI Tightens AI Safety Monitoring After Security Incidents
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook 



